AUPH · NASDAQ · Biotechnology

Aurinia Pharmaceuticals (AUPH)

Markets LUPKYNIS for lupus nephritis and develops additional autoimmune therapies.

$16.40
After hours+0.01 (+0.06%)
At close$16.39(−1.68%)